Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Early hair loss may indicate prostate issues.

Early hair loss may indicate future prostate issues.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Men with enlarged prostates often have more severe baldness.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

CEC levels may be a useful marker for predicting prostate cancer progression.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Certain drugs that block specific enzymes can help treat prostate diseases.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.